Rchr
J-GLOBAL ID:201801021027706482   Update date: Apr. 30, 2024

Norifumi Harimoto

ハリモト ノリフミ | Norifumi Harimoto
Affiliation and department:
Job title: Lecturer
Research field  (1): General surgery, pediatric surgery
Research theme for competitive and other funds  (13):
  • 2023 - 2026 Impact of sarcopenia and creation of novel therapeutic targets by immunotherapeutic resistance mechanisms in hepatocellular carcinoma
  • 2022 - 2025 肝がんの分化規定遺伝子の同定と革新的治療法の開発
  • 2019 - 2022 Evaluation of the effect of sarcopenia on liver regeneration from the viewpoint between liver and muscle correlation
  • 2019 - 2022 A new liver regeneration molecular mechanism involving hepatic stellate cells, Kupffer cells, and glucose-regulated protein 78 as a new hepatotrophic factor
  • 2018 - 2021 New humoral factor facilitates hepato-biliary and pancreatic cancer progression and development of innovative thrapy
Show all
Papers (381):
  • Akira Watanabe, Norifumi Harimoto, Kenichiro Araki, Takamichi Igarashi, Mariko Tsukagoshi, Norihiro Ishii, Kei Hagiwara, Katsuhiko Tsunekawa, Masami Murakami, Ken Shirabe. Perioperative pancreaticoduodenectomy management strategy focusing on postoperative early drain colonization. Surgery today. 2024
  • Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, et al. Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer. Cancer Science. 2024
  • Norifumi Harimoto, Mariko Tsukagoshi, Takaomi Seki, Kouki Hoshino, Kei Hagiwara, Norihiro Ishii, Takamichi Igarashi, Kenichiro Araki, Koichiro Haruki, Toru Ikegami, et al. Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC. International journal of clinical oncology. 2024. 29. 2. 195-204
  • Kouki Hoshino, Seshiru Nakazawa, Takehiko Yokobori, Kei Hagiwara, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Kenichiro Araki, Norifumi Harimoto, Fuminori Tokunaga, et al. RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation. Scientific reports. 2024. 14. 1. 346-346
  • Yoshihiko Maehara, Eiji Oki, Mitsuhiko Ota, Norifumi Harimoto, Koji Ando, Ryota Nakanishi, Tetsuro Kawazoe, Yoshiaki Fujimoto, Kentaro Nonaka, Hiroyuki Kitao, et al. Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii. International journal of clinical oncology. 2023. 28. 5. 613-624
more...
MISC (695):
  • 播本 憲史, 伴 大輔, 星野 弘毅, 村主 遼, 山中 崇弘, 萩原 慶, 石井 範洋, 塚越 真梨子, 渡辺 亮, 新木 健一郎, et al. 地域基幹病院における高難度鏡視下手術の安全な実践と後進への教育について カタバートレーニングを活用した腹腔鏡下膵体尾部切除術の定型化. 日本内視鏡外科学会雑誌. 2021. 26. 7. CSY11-7
  • 新木 健一郎, 村主 遼, 星野 弘毅, 山中 崇弘, 萩原 慶, 石井 範洋, 塚越 真梨子, 渡辺 亮, 播本 憲史, 調 憲. ICG蛍光法を用いた腹腔鏡下肝亜区域切除における区域間静脈ナビゲーションの可能性. 日本内視鏡外科学会雑誌. 2021. 26. 7. MO053-6
  • 塚越 真梨子, 播本 憲史, 新木 健一郎, 久保 憲生, 渡辺 亮, 五十嵐 隆通, 石井 範洋, 萩原 慶, 山中 崇弘, 調 憲. 血友病合併の肝細胞癌に対し腹腔鏡下肝部分切除術を施行した2例. 日本内視鏡外科学会雑誌. 2021. 26. 7. MO077-3
  • 星野 弘毅, 矢島 俊樹, 播本 憲史, 村主 遼, 萩原 慶, 山中 崇弘, 石井 範洋, 塚越 真梨子, 渡辺 亮, 新木 健一郎, et al. 抗原特異的CD8+T細胞誘導マウス腫瘍モデルを用いた動態解析. 日本癌治療学会学術集会抄録集. 2021. 59回. O15-4
  • 村主 遼, 矢島 俊樹, 星野 弘毅, 栗山 健吾, 塚越 真梨子, 山中 崇弘, 萩原 慶, 石井 範洋, 渡辺 亮, 新木 健一郎, et al. 抗原特異的CD8陽性T細胞の疲弊化誘導における各免疫チェックポイント分子の役割. 日本癌治療学会学術集会抄録集. 2021. 59回. O15-5
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page